Toxic epidermal necrolysis treatment and outcomes: a retrospective analysis of 10 patients treated with intravenous immunoglobulin

Int J Dermatol. 2016 Jun;55(6):e356-60. doi: 10.1111/ijd.13156. Epub 2015 Dec 23.

Authors

Darius Mehregan¹, Anthony Van Vreede¹, Mark Goralewski²

Affiliations

¹ Department of Dermatology, Wayne State University School of Medicine, Detroit, MI, USA.
² Department of Dermatology, Wayne State University School of Medicine, Detroit, MI, USA. mgoralew@med.wayne.edu.

PMID: 26694974
DOI: 10.1111/ijd.13156

No abstract available

Publication types

Letter

MeSH terms

Adult
Body Surface Area
Burn Units
Child
Female
Humans
Immunoglobulins, Intravenous / therapeutic use*
Immunologic Factors / therapeutic use*
Male
Middle Aged
Retrospective Studies
Severity of Illness Index
Stevens-Johnson Syndrome / drug therapy*
Stevens-Johnson Syndrome / therapy
Survival Rate
Treatment Outcome
Young Adult

Substances

Immunoglobulins, Intravenous
Immunologic Factors